Medical News

RSS

NIH grant funds trial of wellness intervention for TBI caregivers

A University of Cincinnati College of Medicine physician-researcher has received a five-year, $2.5 million R01 grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health (NIH), marking a major career milestone.

6 Oct 2026

Blood protein patterns may help explain pain levels in sickle cell disease

A small pilot study led by a Rutgers researcher has found differences in blood proteins between people experiencing high and low levels of pain from sickle cell disease, findings that may inform research on new treatments and better pain management.

6 Oct 2026

Poorly validated research antibodies linked to millions of wasted samples

A widespread failure to validate research antibodies before use is estimated to lead to the avoidable waste of millions of animal and human tissue samples worldwide, and an international expert panel has reached consensus on how to address the problem, according to two studies published October 6th in the open access journal PLOS Biology by Harvinder Virk of the University of Leicester, UK, and colleagues.

6 Oct 2026

NCCN summit highlights strategies to improve cancer prevention and screening

The National Comprehensive Cancer Network (NCCN) hosted a two-day summit focused on expanding access to life-saving cancer prevention and screening.

6 Oct 2026

Study identifies RGS4 protein as potential target for chronic pain

Chronic pain can continue long after an initial injury. When a nerve outside the brain and spinal cord (a peripheral nerve) is damaged and does not heal properly, it keeps sending constant pain signals.

6 Oct 2026

Psychopathic traits linked to distinct patterns in everyday language

Popular culture often depicts people with psychopathy as cold, emotionless and hollow, but a recent University of Mississippi study found that the language associated with psychopathic traits is more complicated than often described.

6 Oct 2026

Psilocybin users with depression report higher unmet healthcare needs

In a nationally representative study on psilocybin use and mental health treatment, researchers at the University of California San Diego School of Medicine have found that among people with depression, those who use psilocybin pursue mental health care at similar rates to nonusers.

6 Oct 2026

USC researchers receive $4 million to test psychedelic therapy and mindfulness for depression

A team of USC researchers has received an up to $4 million award from the Advanced Research Projects Agency for Health (ARPA-H) to conduct a clinical trial of psychedelic therapy and mindfulness training for depression.

6 Oct 2026

Genetic and tissue analysis reveals new targets for lymphatic malformations

Lymphatic malformations are rare disorders in which lymph vessels develop abnormally, often beginning in childhood and sometimes causing swelling, infection, bleeding, pain, or airway obstruction.

6 Oct 2026

Global scientific collaboration brings hope to lobular breast cancer patients

Every October, Breast Cancer Awareness Month brings people around the world together under the pink ribbon to raise awareness, encourage early detection, support patients and fund research.

6 Oct 2026

UCLA researcher wins the 2026 Albany Prize for revolutionary cancer therapy discoveries

Dr. Dennis Slamon, a pioneering oncologist and researcher at the UCLA Health Jonsson Comprehensive Cancer Center, has been awarded the 2026 Albany Prize for discoveries that transformed the understanding and treatment of cancer.

6 Oct 2026

New AI model detects heart transplant rejection without biopsies

By analyzing heart rhythm recordings and blood tests, artificial intelligence may accurately flag when a transplant patient's body starts attacking a donated heart, a new study suggests.

6 Oct 2026

Scientists discover a novel strategy to unmask cancer cells in high-risk neuroblastoma

High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous system.

6 Oct 2026

New review identifies pistachios as a promising whole food for sleep research

Nearly one-third of U.S. adults report sleeping less than seven hours a night, below the minimum amount recommended for most adults, while nearly one in five has trouble staying asleep most days or every day.

6 Oct 2026

New global definition changes how childhood obesity is identified

A new global definition of clinical obesity classifies far fewer children as obese than the widely used body mass index (BMI), according to a large international study. And the findings could lead to changes to how childhood obesity is identified and managed.

6 Oct 2026

Study uncovers link between inherited blindness and a gene causing rare metabolic disease

Researchers at the Greenwood Genetic Center (GGC) led the discovery of an unexpected connection between inherited blindness and a gene known for causing a rare metabolic disorder.

6 Oct 2026

Novel peptide approach reduces chronic neuropathic pain in mice

Understanding and treating chronic neuropathic pain has remained challenging due to its complex nature. New research from the lab of Clifford Woolf, MB, BCh, PhD, at Boston Children's Hospital's FM Kirby Neurobiology Center describes a novel approach for reducing pain by disrupting interactions within pain-sensing nerve cells called nociceptors

6 Oct 2026

Timing of brain surgery critical for certain Parkinson's patients

The timing of Deep Brain Stimulation (DBS) surgery is a critical factor in preserving cognitive function for Parkinson's disease patients with a specific genetic mutation, according to a new study by an international team of researchers.

6 Oct 2026

Mini-GRID radiotherapy limits cellular senescence in glioma models

A new research paper was recently published in Volume 18 of Aging, titled "Spatially fractionated mini-GRID radiotherapy differentially modulates radiation-induced senescence in murine glioma and normal cells."

6 Oct 2026

SGLT2 inhibitors reduce inflammatory cells linked to heart disease

For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight loss and glucose lowering benefits, has been shown to also reduce inflammatory cells in the blood known to cause cardiovascular disease.

6 Oct 2026